ArticleFrontiers in oncology2025
Development and validation of hybrid machine learning approach for predicting survival in patients with cervical cancer: a SEER-based population study.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Accurate survival prediction in cervical cancer is crucial for personalized therapy, particularly in high-risk groups where early intervention might enhance results. The study aims to create a hybrid survival model that integrates Cox Proportional Hazards (CoxPH) with Elastic Net regularization and Random Survival Forest (RSF) to improve prediction accuracy and interpretability. Methods: Data from the SEER database (2013-2015) were pre-processed through normalization and encoding. RSF recorded non-linear interactions between covariates, while the CoxPH Elastic Net Regularization model provided linear interpretability and identified key variables. Model parameters were optimized using cross-validation, and final performance was assessed on an independent test set using metrics including C-index, Integrated Brier Score (IBS), AUC-ROC, and calibration plots. Results: The hybrid model outperformed the individual models with an Integrated Brier Score (IBS) of 0.13 and a concordance index (C-index) of 0.82. With an AUC-ROC of 0.84, the model provided robust calibration and classification performance on the independent test set, effectively separating between individuals at high and low risk. Conclusion: The hybrid model provides a promising tool for personalized risk stratification in cervical cancer based on survival probability. Further testing in varied clinical categories is recommended to confirm its efficiency in precision oncology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.